Hallucinogens alter perception, mood, and thought by disrupting the brain’s normal signaling patterns, but they also produce a range of measurable physical effects: increased heart rate, elevated blood pressure, raised body temperature, and dilated pupils. These changes begin within 20 to 50 minutes for most substances and can last anywhere from one hour to over 11 hours depending on the drug. Here’s what’s happening inside your body and brain during that window.
How Hallucinogens Work in the Brain
Classic hallucinogens like LSD, psilocybin (the active compound in “magic mushrooms”), and DMT (found in ayahuasca) all work primarily by activating serotonin receptors, specifically a type called 5-HT2A. Serotonin is a chemical messenger involved in mood, perception, and cognition. When a hallucinogen locks onto these receptors, it triggers a cascade of signaling inside the cell that changes how neurons communicate with each other. The result is a profound shift in how your brain processes sensory information, emotions, and your sense of self.
Not all hallucinogens work this way. Dissociative drugs like ketamine and PCP block a different type of receptor involved in learning and memory. This produces a distinct experience: feelings of detachment from the body, numbness, and cognitive disruption rather than the vivid sensory distortions typical of classic psychedelics. The physical and psychological effects differ meaningfully between these two classes.
Physical Effects on the Body
Even though hallucinogens are best known for their mental effects, they produce real, measurable changes throughout the body. The cardiovascular system is the most consistently affected. At a standard dose, LSD increases systolic and diastolic blood pressure and heart rate. Psilocybin similarly raises blood pressure and heart rate in healthy volunteers. DMT, whether injected or consumed in ayahuasca, increases heart rate, blood pressure, body temperature, pupil diameter, and breathing rate. These autonomic responses kick in quickly, typically within 5 to 10 minutes for fast-acting compounds like DMT.
Hormonal shifts also occur. DMT has been shown to increase levels of cortisol (a stress hormone), prolactin, and adrenocorticotropic hormone, which signals the adrenal glands. These changes reflect a broad activation of the body’s stress response system, even if the subjective experience feels euphoric rather than threatening.
For most healthy people, these physical effects are temporary and resolve as the drug wears off. The estimated lethal dose of LSD ranges from 200 micrograms per kilogram of body weight to over 1 milligram per kilogram, and most sources note that no confirmed lethal overdose from LSD alone has ever been reported in humans. The primary physical danger with classic hallucinogens tends to come from risky behavior during intoxication rather than direct organ toxicity.
What Happens in the Brain During a Trip
Brain imaging studies reveal a striking pattern during a psychedelic experience. Under normal conditions, your brain operates in somewhat modular networks, groups of regions that talk mostly to each other. One of the most important is the default mode network, a set of interconnected brain areas that becomes active when you’re daydreaming, reflecting on yourself, or thinking about the past and future. It’s closely linked to your sense of identity and the running narrative in your head.
Hallucinogens consistently reduce the internal connectivity of this network while increasing communication between brain regions that don’t normally talk to each other. The brain shifts from a more segregated, modular structure to a more globally interconnected one. This rewiring is temporary, but it maps closely onto the subjective experience: the loosening of rigid thought patterns, the blurring of boundaries between senses, and the dissolution of the ordinary sense of self that many people report. LSD, psilocybin, and ayahuasca all produce this same signature pattern on brain scans.
How Dissociatives Feel Different
Dissociative hallucinogens produce a noticeably different set of effects. In clinical settings where patients received ketamine infusions, the most commonly reported experiences were feeling “weird, strange, or bizarre” (78% of patients), feeling spacey (74%), dissociation from the body (62%), visual distortions (57%), a floating sensation (55%), and numbness (53%). About half reported difficulty speaking, and 38% experienced confusion.
PCP, a more potent dissociative, carries additional risks. Acute effects include hallucinations, delusions, thought disorders, and in some cases, violent or aggressive behavior. This is a significant difference from classic psychedelics, which rarely produce aggression. The altered mental states from dissociatives vary widely by individual, dose, and specific drug, ranging from sedation to euphoria to, in rare cases, suicidal thoughts.
Timeline of Effects
The duration of a hallucinogenic experience varies considerably by substance. LSD has one of the longest timelines: effects begin within about 25 to 35 minutes, and the full experience lasts 10 to 11 hours. Psilocybin takes slightly longer to kick in, around 50 minutes, but the total experience is shorter at 6 to 7 hours. Both substances produce measurable after-effects for up to 24 hours, including residual changes in mood and mild physical symptoms.
DMT is at the other extreme. When injected, its effects begin within 5 to 10 minutes and the experience is largely over within an hour. When consumed as ayahuasca (which contains a compound that slows DMT’s breakdown in the gut), the timeline extends considerably, with a half-life of roughly four hours.
Tolerance Builds Rapidly
One unusual feature of classic hallucinogens is how fast tolerance develops. A single dose can reduce the density of serotonin 5-HT2A receptors in the brain’s frontal cortex within 24 hours. After four consecutive days of use, the behavioral response to LSD drops by roughly 50%. This is why taking the same dose on consecutive days produces progressively weaker effects.
Cross-tolerance also occurs between different psychedelics that act on the same receptor. If you’ve recently taken LSD, psilocybin will feel weaker too. Sensitivity typically resets after about one to two weeks of abstinence, as receptor density returns to baseline.
Effects on Brain Growth and Flexibility
A growing body of research shows that hallucinogens promote neuroplasticity, the brain’s ability to form new connections and reorganize existing ones. A review of 20 studies found that a single dose of a psychedelic produces rapid changes at multiple levels: gene expression, protein production, the structure of individual neurons, and the formation of new synapses. One key protein affected is brain-derived neurotrophic factor (BDNF), which supports the survival and growth of nerve cells. Repeated administration has been shown to increase BDNF levels for up to a month after treatment and to directly stimulate the growth of new neurons.
These neuroplasticity effects are a major reason psychedelics are being investigated as treatments for depression and PTSD. The idea is that the temporary increase in brain flexibility may allow people to break out of entrenched patterns of negative thinking, essentially creating a window of heightened adaptability that therapy can leverage.
Lasting Perceptual Changes
For a small percentage of people, visual disturbances persist long after a hallucinogen has left the body. This condition, known as hallucinogen persisting perception disorder (HPPD), affects an estimated 4% to 4.5% of people with a history of hallucinogen use. Symptoms include visual snow, trailing images, halos around objects, or geometric patterns that continue appearing weeks or months after the last dose. To qualify as HPPD, these perceptual disturbances must cause significant distress in daily life and cannot be explained by another medical condition. It’s recognized in the DSM-5 as a formal diagnosis, and while it can be distressing, it does not involve a full psychotic break or loss of contact with reality.